60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心已开放病人入组,地点位于西奈山伊坎医学院

美股速递
Nov 21, 2025

60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心现已开放病人入组,地点位于西奈山伊坎医学院。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10